Brainstorm Research Development from 2010 to 2026

BCLI Stock  USD 0.60  0.01  1.69%   
Brainstorm Cell's Research Development is increasing with stable movements from year to year. Research Development is estimated to finish at about 7 M this year. For the period between 2010 and 2026, Brainstorm Cell, Research Development quarterly trend regression had mean deviation of  5,451,293 and range of 21.4 M. View All Fundamentals
 
Research Development  
First Reported
2004-12-31
Previous Quarter
1.1 M
Current Value
899 K
Quarterly Volatility
2.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Brainstorm Cell financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Brainstorm Cell's main balance sheet or income statement drivers, such as Depreciation And Amortization of 226.4 K, Interest Expense of 65.8 K or Selling General Administrative of 4.4 M, as well as many indicators such as Price To Sales Ratio of 17.14, Dividend Yield of 0.0 or Days Sales Outstanding of 21.66. Brainstorm financial statements analysis is a perfect complement when working with Brainstorm Cell Valuation or Volatility modules.
  
Build AI portfolio with Brainstorm Stock
Check out the analysis of Brainstorm Cell Correlation against competitors.
The Research Development trend for Brainstorm Cell Therapeutics offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Brainstorm Cell is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Brainstorm Cell's Research Development Growth Pattern

Below is the plot of the Research Development of Brainstorm Cell Therapeutics over the last few years. It is Brainstorm Cell's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Brainstorm Cell's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Pretty Stable
   Research Development   
       Timeline  

Brainstorm Research Development Regression Statistics

Arithmetic Mean8,216,072
Geometric Mean5,751,680
Coefficient Of Variation79.47
Mean Deviation5,451,293
Median5,072,650
Standard Deviation6,528,973
Sample Variance42.6T
Range21.4M
R-Value0.24
Mean Square Error42.8T
R-Squared0.06
Significance0.35
Slope310,449
Total Sum of Squares682T

Brainstorm Research Development History

2026M
20255.1 M
20244.4 M
202310.5 M
202214 M
202115.2 M
202022.3 M

About Brainstorm Cell Financial Statements

Investors use fundamental indicators, such as Brainstorm Cell's Research Development, to determine how well the company is positioned to perform in the future. Although Brainstorm Cell's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Research Development5.1 MM

Currently Active Assets on Macroaxis

When determining whether Brainstorm Cell Ther offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainstorm Cell's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainstorm Cell Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainstorm Cell Therapeutics Stock:
Check out the analysis of Brainstorm Cell Correlation against competitors.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is there potential for Biotechnology market expansion? Will Brainstorm introduce new products? Factors like these will boost the valuation of Brainstorm Cell. Projected growth potential of Brainstorm fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Brainstorm Cell listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.42)
Return On Assets
(4.00)
Return On Equity
(11.22)
The market value of Brainstorm Cell Ther is measured differently than its book value, which is the value of Brainstorm that is recorded on the company's balance sheet. Investors also form their own opinion of Brainstorm Cell's value that differs from its market value or its book value, called intrinsic value, which is Brainstorm Cell's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Brainstorm Cell's market value can be influenced by many factors that don't directly affect Brainstorm Cell's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Brainstorm Cell's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Brainstorm Cell should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Brainstorm Cell's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.